OUR THERAPIES

The only active devices that provide interventional physicians with greater treatment options and the ability to tailor endovascular procedures to every patient.

OUR THERAPIES

The only active devices that provide interventional physicians with greater treatment options and the ability to tailor endovascular procedures to every patient.

Ischemic Stroke 

87% of all strokes are ischemic and caused by a blood clot that disrupts blood flow in the brain. Active thrombectomy with TIGERTRIEVER™  enables fast revascularization and real-time adjustability for better patient outcomes. 

Ischemic Stroke 

87% of all strokes are ischemic and caused by a blood clot that disrupts blood flow in the brain. Active thrombectomy with TIGERTRIEVER™  enables fast revascularization and real-time adjustability for better patient outcomes. 

Hemorrhagic Stroke

Hemorrhagic stroke is caused by a blood vessel that ruptures in the brain. COMANECI™ is the only non-occlusive, active assist device to treat wide-neck aneurysms without occluding blood flow or permanent implants. 

Hemorrhagic Stroke

Hemorrhagic stroke is caused by a blood vessel that ruptures in the brain. COMANECI™ is the only non-occlusive, active assist device to treat wide-neck aneurysms without occluding blood flow or permanent implants. 

Neurovascular access

DRIVEWIRE redefines access. Active technology enables distal steering to select vessels and navigate a large range of catheters with ease.

Learn more

Vascular access

DRIVEWIRE redefines access. Active technology enables distal steering to select vessels and navigate a large range of catheters with ease.

Neurovascular access

DRIVEWIRE redefines access. Active technology enables distal steering to select vessels and navigate a large range of catheters with ease.

Questions?

Reach out to learn more about our company and stroke solutions.